Atabey N - Search Results

1

Ezrin Enhances EGFR Signaling and Modulates Erlotinib Sensitivity in Non-Small Cell Lung Cancer Cells.

Saygideğer-Kont Y, Minas TZ, Jones H, Hour S, Çelik H, Temel I, Han J, Atabey N, Erkizan HV, Toretsky JA, Üren A. Saygideğer-Kont Y, et al. Among authors: atabey n. Neoplasia. 2016 Feb;18(2):111-20. doi: 10.1016/j.neo.2016.01.002. Neoplasia. 2016. PMID: 26936397 Free PMC article.

2

HGF/c-Met overexpressions, but not met mutation, correlates with progression of non-small cell lung cancer.

Gumustekin M, Kargi A, Bulut G, Gozukizil A, Ulukus C, Oztop I, Atabey N. Gumustekin M, et al. Among authors: atabey n. Pathol Oncol Res. 2012 Apr;18(2):209-18. doi: 10.1007/s12253-011-9430-7. Epub 2011 Jul 21. Pathol Oncol Res. 2012. PMID: 21779788 Free article.

3

Heparin inhibits Hepatocyte Growth Factor induced motility and invasion of hepatocellular carcinoma cells through early growth response protein 1.

Ozen E, Gozukizil A, Erdal E, Uren A, Bottaro DP, Atabey N. Ozen E, et al. Among authors: atabey n. PLoS One. 2012;7(8):e42717. doi: 10.1371/journal.pone.0042717. Epub 2012 Aug 13. PLoS One. 2012. PMID: 22912725 Free PMC article.

4

Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis.

Bozkaya G, Korhan P, Cokaklı M, Erdal E, Sağol O, Karademir S, Korch C, Atabey N. Bozkaya G, et al. Among authors: atabey n. Mol Cancer. 2012 Sep 11;11:64. doi: 10.1186/1476-4598-11-64. Mol Cancer. 2012. PMID: 22962849 Free PMC article.

5

Active form of AKT controls cell proliferation and response to apoptosis in hepatocellular carcinoma.

Kunter I, Erdal E, Nart D, Yilmaz F, Karademir S, Sagol O, Atabey N. Kunter I, et al. Among authors: atabey n. Oncol Rep. 2014 Feb;31(2):573-80. doi: 10.3892/or.2013.2932. Epub 2013 Dec 16. Oncol Rep. 2014. PMID: 24337632 Free PMC article.

6

MiR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met.

Korhan P, Erdal E, Atabey N. Korhan P, et al. Among authors: atabey n. Biochem Biophys Res Commun. 2014 Aug 8;450(4):1304-12. doi: 10.1016/j.bbrc.2014.06.142. Epub 2014 Jul 21. Biochem Biophys Res Commun. 2014. PMID: 25058462

7

Reciprocal activating crosstalk between c-Met and caveolin 1 promotes invasive phenotype in hepatocellular carcinoma.

Korhan P, Erdal E, Kandemiş E, Cokaklı M, Nart D, Yılmaz F, Can A, Atabey N. Korhan P, et al. Among authors: atabey n. PLoS One. 2014 Aug 22;9(8):e105278. doi: 10.1371/journal.pone.0105278. eCollection 2014. PLoS One. 2014. PMID: 25148256 Free PMC article.

8

Downregulation of VANGL1 inhibits cellular invasion rather than cell motility in hepatocellular carcinoma cells without stimulation.

Cetin GO, Toylu A, Atabey N, Sercan Z, Sakizli M. Cetin GO, et al. Among authors: atabey n. Genet Test Mol Biomarkers. 2015 Jun;19(6):283-7. doi: 10.1089/gtmb.2015.0014. Epub 2015 Apr 15. Genet Test Mol Biomarkers. 2015. PMID: 25874746 Free PMC article.

9

Heparin treatment increases thioredoxin interacting protein expression in hepatocellular carcinoma cells.

Gunes A, Iscan E, Topel H, Avci ST, Gumustekin M, Erdal E, Atabey N. Gunes A, et al. Among authors: atabey n. Int J Biochem Cell Biol. 2015 Aug;65:169-81. doi: 10.1016/j.biocel.2015.05.025. Epub 2015 May 30. Int J Biochem Cell Biol. 2015. PMID: 26037596

10

Targeting c-Met in Cancer by MicroRNAs: Potential Therapeutic Applications in Hepatocellular Carcinoma.

Karagonlar ZF, Korhan P, Atabey N. Karagonlar ZF, et al. Among authors: atabey n. Drug Dev Res. 2015 Nov;76(7):357-67. doi: 10.1002/ddr.21274. Epub 2015 Sep 12. Drug Dev Res. 2015. PMID: 26363180 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters